Sign in
CompletedNo phase

ChitoCare Medical Wound Healing Gel PMCF Study on Healing of Chronic Wounds

Key facts

Who runs it
Primex ehf
Where
Croatia and Slovenia9 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
92 people enrolled
Started
11 Jan 2022
Ended
15 Oct 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • ChitoCare medical Wound Healing Gel
Record updated
19 February 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Written informed consent must be given
  • Patient ≥ 18 years old
  • Presence of chronic wound (Wagner grade I and II diabetic foot ulcer, venous leg ulcer or pressure ulcer) that meets the following criteria:; Size of the wound ≥ 0.5 cm2; Wound is not infected at the time of randomization; Wound is present for at least 4 weeks
  • Able to understand and comply with the requirements of the study

Who cannot take part

  • Previous treatment under this clinical protocol
  • Receiving or scheduled to receive a medication or treatment which, in the opinion of the investigator, was known to interfere with, or affect the rate and quality of wound healing
  • Any significant condition that may preclude the participant from the study (e.g. severe depression or psychiatric illness)
  • Patients that will require surgical procedure to treat their ischemic condition on the limb where the wound is present as assessed by the investigator
  • Patients diagnosed with autoimmune connective tissue diseases
  • Allergy to shellfish (for active study group)
  • Medical condition likely to require systemic corticosteroids during the study period
  • Patients with serious concomitant disease (cancer, heart failure (NYHA class IV), severe anaemia (Hb<100 g/L), neoplasia)
  • Participation in another clinical trial
  • Pregnant and lactating women

Where is this trial?

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

We are testing a gel intended for the protection and healing of chronic wounds as a support for standard therapy. The main component of the gel is chitosan, a natural polymer that has the ability to stop bleeding, has a positive effect on wound healing, and has antimicrobial properties.

The 2 groups in the trial

  • Active groupTreatment being tested

    Active group will apply ChitoCare medical Wound Healing Gel to the wound in addition to standard of care.

    Treatment: ChitoCare medical Wound Healing Gel

  • Control groupNo study treatment, for comparison

    Control group will only administer standard of care to treat their wounds.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multi-Centre, Randomized, 2-arm, Open-labelled, Controlled PMCF Study to Evaluate the Safety and Performance of ChitoCare Medical Wound Healing Gel in Healing of Chronic Wounds
Record updated
19 February 2025